Parestehesia
Conditions
Interventions
This is a two-arm, triple-blind, randomized controlled clinical study. Participants will be placed into 3 groups, through a draw,with 40 participants allocated per group. The 3 groups will be: 1, 2, 3
the chin, cheeks, lips and gums will also be irradiated. Group 2: 40 participants will receive photobiomodulation therapy, 660 and 808 nm, simultaneously, 100mW, 20s/point, 2J of energy/point of each
the chin, cheeks, lips and gums will also be irradiated. Group 3: 40 participants will receive the photobiomodulation therapy simulation with the laser used in off mode (sham), distance of 1 cm betwe
The chin, cheeks, lips and gums will also be irradiated. The laser application will be carried out by a trained researcher, using equipment that applies light to the tissues to be treated, at pre-esta
E02.594.540
E02.190
Sponsors
Faculdade de Odontologia da Universidade de São Paulo
Faculdade de Odontologia da Universidade de São Paulo
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Will be included, adults aged between 18 and 60 years; of both sexes and regardless of color or social class; with a main complaint of inferior alveolar nerve paresthesia who underwent orthognathic surgery or third molar extraction; who seek or are referred to "Laboratório Especial de Laser em Odontologia da Universidade de São Paulo" for the treatment of paresthesia; to all participants will be asked to sign the free and informed consent form
Exclusion criteria
Exclusion criteria: Participants with paresthesia unrelated to orthognathic surgery or third molar extraction will be excluded; patients who also present lingual nerve paresthesia; patients with sensory changes reported before surgery or with a history of injury to trigeminal nervous tissue due to other interventions; patients who present paresthesia of the maxillary and/or mandibular branches of the trigeminal nerve and are undergoing some other type of treatment for paresthesia (Acupuncture; systemic medication; local physiotherapy; electrical stimulation); be using antidepressant or anxiolytic medications, and pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate improvement in inferior alveolar nerve paresthesia after photobiomodulation therapy, using sensitivity assessment forms, visual analogue scale (VAS) and Oral Health Impact Profile (OHIP-14) | — |
Secondary
| Measure | Time frame |
|---|---|
| no secondary outcome is expected | — |
Countries
Brazil
Contacts
Public ContactIsabella Polho
Faculdade de Odontologia da Universidade de São Paulo
Outcome results
None listed